Guadalupe Medical Innovations San Antonio, TX - 78228

Guadalupe Medical Innovations is categorized under Health Services in San Antonio, TX and active since 2009.

Guadalupe Medical Innovations was established in 2009, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 6219992 by the NAICS.

If you are seeking more information, feel free to contact Claudia Martinez, Administrator at the company’s single location by writing to 3503 Lura Lane, San Antonio, Texas TX 78228 or by phoning (210) 736-4399. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Guadalupe Medical Innovations
Contact Person: Claudia Martinez, Administrator
Address: 3503 Lura Lane, San Antonio, Texas 78228
Phone Number: (210) 736-4399
Annual Revenue (USD): $500.000 to $999.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Health Services
SIC Code: 8099
NAICS Code: 6219992
Share This Business:

Guadalupe Medical Innovations was started in 2009 to provide professional Health Services under the SIC code 8099 and NAICS code 6219992. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Claudia Martinez, Administrator for inquiries that concern Guadalupe Medical Innovations by calling the company number (210) 736-4399, as your correspondence is most welcome. Additionally, the physical location of the single location of Guadalupe Medical Innovations can be found at the coordinates 29.46906,-98.58547 as well as the street address 3503 Lura Lane in San Antonio, Texas 78228.

For its online presence, you may visit Guadalupe Medical Innovations’s website at and engage with its social media outlets through on Twitter and on Facebook.